Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Text messages may boost mental health care for new and expecting mothers

NCT ID NCT05764213

First seen Nov 15, 2025 · Last updated Jun 20, 2026 · Updated 35 times

Summary

This study compares a text message-based mental health and substance use screening program (Listening to Women & Pregnant and Postpartum People) to standard in-person screening. Over 10,000 pregnant and postpartum people will participate. The goal is to see if the text-based approach increases treatment attendance and retention, and reduces symptoms of depression and anxiety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

text message-based screening and remote care coordination

What this could lead to

If successful, this could make mental health and substance use screening more accessible and effective for pregnant and postpartum people, leading to better treatment engagement.

What could go wrong

This is a large but early-stage behavioral study, so results may vary by clinic and population. The intervention relies on text messaging, which may not work for everyone.

Conditions

The condition(s) this trial relates to.

postpartum depression substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.